U.S. Health System Needs "Innovation Criteria" To Guide Reimbursement, J&J Exec Says
This article was originally published in The Pink Sheet Daily
Executive Summary
"The health care system cannot afford to continue to invest in all innovations at the same rate," Biopharmaceuticals Group Chairman Joseph Scodari said.